Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study

enthalten in: EClinicalMedicine | 2020

von Albani, F. | Sepe, L. | Fusina, F. | +9